vulva cancer
Showing 1 - 25 of >10,000
Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Recurrent Vulvar Cancer
- +3 more
- (no location specified)
Jun 12, 2023
SLN Mapping and ICG Dye for Vulvar Cancer
Not yet recruiting
- Vulva Cancer
- Indocyanine green
-
Boston, MassachusettsTufts Medical Center
Sep 6, 2023
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)
Recruiting
- Advanced Solid Tumor
- +8 more
- CNSI-Fe(II) 30 mg
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Sep 15, 2023
Sentinel Node Extended in Squamous Cell Vulvar Cancer
Recruiting
- Vulva Cancer
- Sentinel Lymph Node
- Sentinel node biopsy
-
Stockholm, Stockholms Lan, Sweden
- +3 more
Aug 17, 2022
Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear
Recruiting
- Breast Carcinoma
- +9 more
- Indocyanine green
- +3 more
-
Vandoeuvre-les-Nancy, FranceInstitut de Cancérologie de Lorraine
Mar 29, 2022
Vulva Cancer, Recurrent, Vulvar Squamous Cell Carcinoma, Vulva Cancer Trial (DaRT Diffusing Alpha-emitters Radiation Therapy)
Not yet recruiting
- Vulva Cancer, Recurrent
- +2 more
- DaRT Diffusing Alpha-emitters Radiation Therapy
- (no location specified)
Feb 17, 2021
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine
Not yet recruiting
- Cervical Cancer
- +5 more
- HRYZ-T101 Injection
- Fludarabine + Cyclophosphamide
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 17, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,
Not yet recruiting
- Cervical Cancer
- +6 more
- Fludarabine + Cyclophosphamide
- HRYZ-T101 TCR-T Cell
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 27, 2023
Cervical Cancer, Uterine Cancer, Vaginal Cancer Trial in Boston (Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine)
Completed
- Cervical Cancer
- +3 more
- Image-guided brachytherapy
- 3'-Deoxy-3'-18f-Fluorothymidine
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 8, 2022
Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 21, 2021
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Breast Cancer, Genitourinary Syndrome of Menopause Trial in Miami (Platelet-rich plasma (PRP))
Not yet recruiting
- Breast Cancer
- Genitourinary Syndrome of Menopause
- Platelet-rich plasma (PRP)
-
Miami, FloridaUniversity of Miami
Mar 31, 2023
Construction of Gynecological Tumor Organoids
Not yet recruiting
- Gynecologic Cancer
- Organoid
- construction of organoids from gynecological tumor
- (no location specified)
Nov 23, 2023
Stage III Vulvar Cancer AJCC v7, Stage IIIA Vulvar Cancer AJCC v7, Stage IIIB Vulvar Cancer AJCC v7 Trial in United States
Active, not recruiting
- Stage III Vulvar Cancer AJCC v7
- +5 more
- Cisplatin
- +3 more
-
Birmingham, Alabama
- +192 more
Dec 1, 2021
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
Unknown status
- Cervical Dysplasia
- +4 more
- OCT-AFI
-
Vancouver, British Columbia, CanadaVancouver General Hospital Women's Clinic
Jan 21, 2020
Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)
Active, not recruiting
- Squamous Cell Lung Cancer
- +5 more
- pembrolizumab; vorinostat
-
Angers, France
- +13 more
Jan 4, 2023
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo
Recruiting
- Cancer, All Types
- +44 more
-
Gainesville, GeorgiaSpecicare
Dec 2, 2020
Quality of Life in Patients Undergone Vulvar Reconstruction
Recruiting
- Vulvar Neoplasms
- Quality of life questionnaires
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Nov 13, 2023
Cervical Cancers, Vulvar Cancer, Vaginal Cancer Trial in Hanzhou (9-valent HPV Recombinant Vaccine, Placebo)
Completed
- Cervical Cancers
- +14 more
- 9-valent HPV Recombinant Vaccine
- Placebo
-
Hanzhou, ChinaZhejiang Provincial Center for Disease Control and Prevention
Jan 20, 2020
Breast Cancer Female Trial (Vaginal Lactobacillus capsules)
Not yet recruiting
- Breast Cancer Female
- Vaginal Lactobacillus capsules
- (no location specified)
Aug 2, 2023
HPV Infection, Vaginal Cancer, Cervical Dysplasia Trial in Orléans (Vaginal Biopsy)
Recruiting
- HPV Infection
- +3 more
- Vaginal Biopsy
-
Orléans, FranceCHR Orléans
Apr 5, 2022
Vulvar Cancer Individualized Scoring System (VCISS)
Not yet recruiting
- Vulvar Cancer
- Machine learning-based prediction model
-
Alexandria, Egypt
- +1 more
Aug 22, 2023